Exact Sciences
EXAS
#1116
Rank
A$28.71 B
Marketcap
A$150.43
Share price
0.00%
Change (1 day)
100.80%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : A$4.96 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are A$4.96 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$5.16 B-8.88%
2024-12-31A$5.66 B16.12%
2023-12-31A$4.88 B4.35%
2022-12-31A$4.67 B2.87%
2021-12-31A$4.54 B30.03%
2020-12-31A$3.49 B101.11%
2019-12-31A$1.73 B45.33%
2018-12-31A$1.19 B1095.65%
2017-12-31A$0.10 B72.83%
2016-12-31A$57.91 M13.49%
2015-12-31A$51.02 M75.18%
2014-12-31A$29.13 M129.72%
2013-12-31A$12.68 M-2.56%
2012-12-31A$13.01 M-0.85%
2011-12-31A$13.12 M-20.46%
2010-12-31A$16.5 M-24.67%
2009-12-31A$21.9 M85.49%
2008-12-31A$11.8 M24.28%
2007-12-31A$9.5 M-15.94%
2006-12-31A$11.3 M-37.46%
2005-12-31A$18.07 M-22.85%
2004-12-31A$23.42 M-22.45%
2003-12-31A$30.2 M45%
2002-12-31A$20.83 M157.24%
2001-12-31A$8.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sanofi
SNY
A$92.80 B 1,770.80%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$0.13 B-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A$0.50 B-89.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A$31.27 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA